Daltroban is a selective and potent thromboxane A2 (TXA2) receptor antagonist; it inhibits platelet aggregation, affects thrombus formation, and prevents sudden death; used in the treatment of myocardial ischemia, hemorrhagic shock, endotoxic shock, cardiopulmonary sudden death, acute renal failure, and atherosclerosis.